Clinical Research Directory

4beta-hydroxycholesterol in Cirrhosis

Sponsor: University of Oulu

Summary

The aim is to evaluate the levels of oxysterols and especially 4beta-hydroxycholesterol in patients with liver cirrhosis. Three cirrhosis cohorts are recruited: patients treated with spironolactone, patients treated with rifaximin, patients without spironolactone or rifaximin. Also three other control cohorts are recruited: patients with pneumonia, patients with Crohn's disease, patients with ulcerative colitis. The effect of the cirrhosis and its medications spironolactone and rifaximin are compared to control groups.

Official title: 4beta-hydroksikolesteroli Maksakirroosissa

Key Details

Conditions

Interventions

Locations (1)